Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America

Ross Levine (Autor)

Buch | Hardcover

240 Seiten

2012
W B Saunders Co Ltd (Verlag)
978-1-4557-4941-6 (ISBN)

Artikel merken

Includes: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; Animal Models of MPNs; and Role of Germline Genetic Factors in MPN Pathogenesis.

Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; Role of novel mutations in MPN pathogenesis and outcome; Role of JAK inhibitors in MPN treatment; Animal Models of MPNs; and Role of Germline Genetic Factors in MPN Pathogenesis.

Human Oncology and Pathogenesis Program. Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Reihe/Serie	The Clinics: Internal Medicine
Verlagsort	London
Sprache	englisch
Maße	152 x 229 mm
Gewicht	400 g
Themenwelt	Medizinische Fachgebiete ► Innere Medizin ► Hämatologie
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
ISBN-10	1-4557-4941-9 / 1455749419
ISBN-13	978-1-4557-4941-6 / 9781455749416
Zustand	Neuware